Department of Internal Medicine, ASST Fatebenefratelli-Sacco, Milan, Italy.
Department of Internal Medicine, ASST Fatebenefratelli-Sacco, Milan, Italy.
Eur J Intern Med. 2023 Jul;113:45-48. doi: 10.1016/j.ejim.2023.03.034. Epub 2023 Apr 15.
This cohort study describes a systemic phenotype of pericarditis, comparing this phenotype with other forms of pericarditis.
Patients in our center were enrolled in a prospectively maintained registry from 2019 to 2022. 412 patients with idiopathic recurrent pericarditis were analyzed. "Systemic inflammatory" subset was defined as the presence of all the following criteria: fever ≥38C°, CRP ≥2 times normal values, pleural effusion detected with any imaging techniques. The absence of any of the 3 criteria was defined as "isolated" subset.
We found that 211 (51.2%) of 412 patients (188 female) presented the systemic subset and the variables significantly associated with this subset in univariate analysis (p<0.001) were: higher mean age: 45.5 (±SD 17.2) vs 39.9 (±SD 16.4) years, higher mean CRP values: 128.8 vs 49.9 mg/L, higher proportion of pericardiocentesis: 19% vs 1.5%, higher mean leukocyte count: 13,143.3 vs 9910.3/mm, higher mean neutrophils number: 10,402.5 vs 6779.8 /mm and lower mean lymphocyte count: 1693.9 vs 2079.3 /mm. As results the neutrophil-to-lymphocyte ratio was higher in systemic inflammatory phenotype: 6.6 vs 3.4 (p< 0.001). Anti-IL1 therapy was started more frequently in the systemic subgroup (26%) than in the isolated subset (7.5%) (p < 0.001). On multivariate analysis neutrophil count and lymphopenia were statistically associated with the systemic subset (p < 0.001).
This results demonstrate the relevance of the systemic inflammatory phenotype, characterized by pleural effusions, confirming its analogy with autoinflammatory diseases, thus possibly requiring an eventual escalation of therapy to IL-1 inhibitors.
本队列研究描述了心包炎的全身表型,并将其与其他形式的心包炎进行了比较。
我们中心的患者于 2019 年至 2022 年期间纳入前瞻性维护的登记处。分析了 412 例特发性复发性心包炎患者。“全身炎症”亚组定义为存在以下所有标准:体温≥38°C,C 反应蛋白(CRP)≥正常值的 2 倍,胸腔积液可通过任何影像学技术检测到。不存在这 3 个标准中的任何一个被定义为“孤立”亚组。
我们发现,412 例患者中有 211 例(51.2%)表现出全身亚组,在单变量分析中与该亚组显著相关的变量(p<0.001)为:更高的平均年龄:45.5(±17.2)岁 vs 39.9(±16.4)岁,更高的平均 CRP 值:128.8 与 49.9mg/L,更高的心包穿刺比例:19%与 1.5%,更高的平均白细胞计数:13143.3 与 9910.3/mm,更高的平均中性粒细胞数:10402.5 与 6779.8/mm,更低的平均淋巴细胞计数:1693.9 与 2079.3/mm。结果,中性粒细胞与淋巴细胞比值在全身炎症表型中更高:6.6 与 3.4(p<0.001)。在全身亚组中更频繁地开始抗 IL-1 治疗(26%)比在孤立亚组(7.5%)中更频繁(p<0.001)。多变量分析显示,中性粒细胞计数和淋巴细胞减少与全身亚组有统计学关联(p<0.001)。
这些结果表明全身炎症表型的重要性,其特征为胸腔积液,证实其与自身炎症性疾病类似,因此可能需要将治疗升级为白细胞介素-1 抑制剂。